Open access publishing fees waived for low income countries
Authors from low income countries will no longer have to pay open access author processing charges, the Biochemical Society and Portland Press Limited today announced.
The move means that, from September 2014, authors from 71 countries can have their accepted papers published and made publicly available for free in the Biochemical Journal (www.biochemj.org), Clinical Science (www.clinsci.org), and the fully open access journal, Bioscience Reports (www.bioscirep.org). Authors from a further 45 countries can receive a discount on their author processing charges.
The initiative is part of push by the Biochemical Society, and its wholly-owned publishing subsidiary Portland Press Limited, to support and boost bioscience in the developing world, says Head of Publishing Niamh O'Connor.
“Portland Press Limited is committed to supporting scientists and researchers in developing countries. We already provide free or very low cost subscriptions to institutions in 116 countries, as part of the HINARI Access to Research in Health Programme.
“We are now going above and beyond that commitment by waiving or reducing author processing charges for authors from these countries, helping to ensure their work is seen on the world stage.”
All Portland Press Limited journals offer a gold open access option, meaning everyone can view the research online as soon as it is published. Papers will continue to undergo robust peer review processes and adhere to strict publishing guidelines.
Biochemical Society Chair Steve Busby says the move reflects the benefit of having a Society-owned publisher. “As a publisher owned by a Society, Portland Press Limited contributes to our mandate to support the advancement of science and the needs of the scientific community. This includes ensuring the breadth of our international community is supported in sharing and discovering knowledge.
“By waiving or reducing author processing charges for authors from low income countries, alongside free access to our journals, we can help boost scientific connections with the developing world and further the Society's goal to advance the molecular biosciences internationally.”
By waiving or reducing author processing charges for authors from low income countries, alongside free access to our journals, we can help boost scientific connections with the developing world and further the Society's goal to advance the molecular biosciences internationally.
Low income countries will be defined by the HINARI Access to Research in Health Programme: http://www.who.int/hinari/eligibility/en.
Portland Press Ltd, a wholly-owned subsidiary of the Biochemical Society, is an innovative publisher of journals, books and electronic resources in the biochemical, cellular and molecular life sciences. The surplus from the sale of publications is returned to the global scientific community via the activity of the Biochemical Society. www.portlandpress.com
The Biochemical Society promotes the advancement of the molecular biosciences, representing the interests of all those working in the sector. The Biochemical Society is the largest discipline-based learned society in the biosciences with more than 6,900 members. www.biochemistry.org
Registered Office: Charles Darwin House, 12 Roger Street, London, WC1N 2JU.
VAT registration number GB 523 2392 69.
The contents of this email are for the recipient only.
If you are not this person (or not responsible for delivery to this person), then notify the sender and delete the email immediately.
Any opinions contained in this message are those of the author and are not given or endorsed by the Biochemical Society or the division through which this message is sent unless otherwise clearly indicated in this message.
Charles Darwin House, 12 Roger Street, London, WC1N 2JU
* You are subscribed to the SERIALST listserv (Serials in Libraries discussion forum)
* To unsubscribe, send an email to the server address: LISTSERV@LIST.UVM.EDU . Do NOT include a subject line. Type as an email message these two words: SIGNOFF SERIALST
* For additional information, see SERIALST Scope, Purpose and Usage Guidelines.